| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | TGFb_propeptide | 8.81e-05 | 28 | 58 | 3 | PF00688 | |
| Domain | TGF-b_N | 8.81e-05 | 28 | 58 | 3 | IPR001111 | |
| Domain | TGF-beta-rel | 1.32e-04 | 32 | 58 | 3 | IPR015615 | |
| Domain | TGFb_CS | 1.32e-04 | 32 | 58 | 3 | IPR017948 | |
| Domain | TGFB | 2.05e-04 | 37 | 58 | 3 | SM00204 | |
| Domain | Cadherin_tail | 2.05e-04 | 37 | 58 | 3 | PF15974 | |
| Domain | TGF-b_C | 2.05e-04 | 37 | 58 | 3 | IPR001839 | |
| Domain | TGF_BETA_2 | 2.05e-04 | 37 | 58 | 3 | PS51362 | |
| Domain | TGF_beta | 2.05e-04 | 37 | 58 | 3 | PF00019 | |
| Domain | TGF_BETA_1 | 2.05e-04 | 37 | 58 | 3 | PS00250 | |
| Domain | Cadherin_CBD | 2.05e-04 | 37 | 58 | 3 | IPR031904 | |
| Domain | Quinoprot_gluc/sorb_DH | 6.13e-04 | 12 | 58 | 2 | IPR011041 | |
| Domain | Cadherin_2 | 1.08e-03 | 65 | 58 | 3 | PF08266 | |
| Domain | Cadherin_N | 1.08e-03 | 65 | 58 | 3 | IPR013164 | |
| Domain | - | 1.18e-03 | 67 | 58 | 3 | 2.10.90.10 | |
| Domain | Cystine-knot_cytokine | 1.18e-03 | 67 | 58 | 3 | IPR029034 | |
| Domain | CTCK_1 | 1.40e-03 | 18 | 58 | 2 | PS01185 | |
| Domain | CT | 2.10e-03 | 22 | 58 | 2 | SM00041 | |
| Domain | Cys_knot_C | 2.72e-03 | 25 | 58 | 2 | IPR006207 | |
| Domain | CTCK_2 | 2.72e-03 | 25 | 58 | 2 | PS01225 | |
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | 2.24e-08 | 18 | 59 | 4 | 15570159 | |
| Pubmed | 2.08e-06 | 15 | 59 | 3 | 15640798 | ||
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 2.76e-06 | 57 | 59 | 4 | 32633719 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 32071240 | ||
| Pubmed | The Growth Differentiation Factor 11 (GDF11) and Myostatin (MSTN) in tissue specific aging. | 2.83e-06 | 2 | 59 | 2 | 28472635 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 30281844 | ||
| Pubmed | Circulating Growth Differentiation Factor 11/8 Levels Decline With Age. | 2.83e-06 | 2 | 59 | 2 | 26489925 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 36631218 | ||
| Pubmed | Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease. | 2.83e-06 | 2 | 59 | 2 | 27304512 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 26372181 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 23818952 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 27034275 | ||
| Pubmed | Supraphysiological levels of GDF11 induce striated muscle atrophy. | 2.83e-06 | 2 | 59 | 2 | 28270449 | |
| Pubmed | Redundancy of myostatin and growth/differentiation factor 11 function. | 2.83e-06 | 2 | 59 | 2 | 19298661 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 10508689 | ||
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | 2.96e-06 | 58 | 59 | 4 | 30377227 | |
| Pubmed | 3.10e-06 | 17 | 59 | 3 | 29911975 | ||
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | 3.72e-06 | 18 | 59 | 3 | 10662547 | |
| Pubmed | The DNA sequence and comparative analysis of human chromosome 5. | 8.30e-06 | 75 | 59 | 4 | 15372022 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 30814254 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 32035222 | ||
| Pubmed | Myostatin suppression of Akirin1 mediates glucocorticoid-induced satellite cell dysfunction. | 8.48e-06 | 3 | 59 | 2 | 23516508 | |
| Pubmed | Structural basis for potency differences between GDF8 and GDF11. | 8.48e-06 | 3 | 59 | 2 | 28257634 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 22798432 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 30165829 | ||
| Pubmed | 9.15e-06 | 24 | 59 | 3 | 24698270 | ||
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 1.47e-05 | 28 | 59 | 3 | 15347688 | |
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 17878677 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 32966780 | ||
| Pubmed | Both WFIKKN1 and WFIKKN2 have high affinity for growth and differentiation factors 8 and 11. | 1.69e-05 | 4 | 59 | 2 | 18596030 | |
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 18535106 | ||
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 27148972 | ||
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 19751112 | ||
| Pubmed | Are voltage-dependent ion channels involved in the endothelial cell control of vasomotor tone? | 4.23e-05 | 6 | 59 | 2 | 17513486 | |
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 20667915 | ||
| Pubmed | 7.87e-05 | 8 | 59 | 2 | 12546816 | ||
| Pubmed | 7.87e-05 | 8 | 59 | 2 | 10380922 | ||
| Pubmed | 7.87e-05 | 8 | 59 | 2 | 31187730 | ||
| Pubmed | Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. | 1.01e-04 | 9 | 59 | 2 | 18083104 | |
| Pubmed | 1.14e-04 | 55 | 59 | 3 | 15342483 | ||
| Pubmed | 1.22e-04 | 284 | 59 | 5 | 29459677 | ||
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | 1.54e-04 | 11 | 59 | 2 | 9655502 | |
| Pubmed | Proteins of the CNR family are multiple receptors for Reelin. | 1.85e-04 | 12 | 59 | 2 | 10612399 | |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 2.15e-04 | 68 | 59 | 3 | 11230163 | |
| Pubmed | 2.54e-04 | 14 | 59 | 2 | 22821687 | ||
| Pubmed | 2.54e-04 | 14 | 59 | 2 | 31857374 | ||
| Pubmed | 2.54e-04 | 14 | 59 | 2 | 31242448 | ||
| Pubmed | 2.54e-04 | 14 | 59 | 2 | 14702098 | ||
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 2.54e-04 | 72 | 59 | 3 | 10380929 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 2.75e-04 | 184 | 59 | 4 | 32908313 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 2.76e-04 | 74 | 59 | 3 | 10817752 | |
| Pubmed | 2.93e-04 | 15 | 59 | 2 | 7543410 | ||
| Pubmed | Regulation of GDF-11 and myostatin activity by GASP-1 and GASP-2. | 2.93e-04 | 15 | 59 | 2 | 24019467 | |
| Pubmed | 3.10e-04 | 77 | 59 | 3 | 10835267 | ||
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 3.47e-04 | 80 | 59 | 3 | 10716726 | |
| Pubmed | 4.75e-04 | 19 | 59 | 2 | 17493606 | ||
| Pubmed | FOXG1 Orchestrates Neocortical Organization and Cortico-Cortical Connections. | 5.27e-04 | 20 | 59 | 2 | 30392794 | |
| Pubmed | Neural crest-derived neurons invade the ovary but not the testis during mouse gonad development. | 5.27e-04 | 20 | 59 | 2 | 30819894 | |
| Pubmed | Evolution of Cortical Neurogenesis in Amniotes Controlled by Robo Signaling Levels. | 5.27e-04 | 20 | 59 | 2 | 29961574 | |
| Pubmed | 5.70e-04 | 1116 | 59 | 8 | 31753913 | ||
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 5.97e-04 | 226 | 59 | 4 | 37839992 | |
| Pubmed | 6.39e-04 | 22 | 59 | 2 | 12812986 | ||
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 6.67e-04 | 100 | 59 | 3 | 25807483 | |
| Pubmed | 8.10e-04 | 650 | 59 | 6 | 38777146 | ||
| Pubmed | 8.96e-04 | 26 | 59 | 2 | 24067654 | ||
| Pubmed | Gamma protocadherins are required for survival of spinal interneurons. | 8.96e-04 | 26 | 59 | 2 | 12467588 | |
| Pubmed | 8.96e-04 | 26 | 59 | 2 | 23988635 | ||
| Pubmed | Conditionals by inversion provide a universal method for the generation of conditional alleles. | 9.66e-04 | 27 | 59 | 2 | 23918385 | |
| Pubmed | Rex1/Zfp42 as an epigenetic regulator for genomic imprinting. | 9.66e-04 | 27 | 59 | 2 | 21233130 | |
| Pubmed | 1.04e-03 | 28 | 59 | 2 | 18617019 | ||
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | 1.10e-03 | 119 | 59 | 3 | 28625976 | |
| Pubmed | 1.11e-03 | 267 | 59 | 4 | 33417871 | ||
| Pubmed | 1.19e-03 | 30 | 59 | 2 | 34780058 | ||
| Pubmed | 1.19e-03 | 30 | 59 | 2 | 19054571 | ||
| Pubmed | A large-scale candidate gene association study of age at menarche and age at natural menopause. | 1.24e-03 | 275 | 59 | 4 | 20734064 | |
| Pubmed | 1.27e-03 | 31 | 59 | 2 | 37816598 | ||
| Pubmed | 1.30e-03 | 126 | 59 | 3 | 16284245 | ||
| Pubmed | 1.62e-03 | 35 | 59 | 2 | 20943929 | ||
| Interaction | PCDHA10 interactions | 4.35e-07 | 22 | 58 | 4 | int:PCDHA10 | |
| Interaction | PCDHA6 interactions | 1.88e-06 | 9 | 58 | 3 | int:PCDHA6 | |
| Interaction | PCDHA11 interactions | 2.12e-05 | 19 | 58 | 3 | int:PCDHA11 | |
| Interaction | BRD1 interactions | 5.66e-05 | 344 | 58 | 7 | int:BRD1 | |
| Interaction | RELN interactions | 6.30e-05 | 27 | 58 | 3 | int:RELN | |
| Interaction | SMAD1 interactions | 6.92e-05 | 243 | 58 | 6 | int:SMAD1 | |
| Interaction | GAS6 interactions | 7.15e-05 | 77 | 58 | 4 | int:GAS6 | |
| Cytoband | 5q35 | 4.04e-04 | 23 | 59 | 2 | 5q35 | |
| Cytoband | 5q31 | 4.49e-04 | 115 | 59 | 3 | 5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 5.98e-04 | 298 | 59 | 4 | chr5q31 | |
| GeneFamily | Clustered protocadherins | 3.53e-04 | 64 | 39 | 3 | 20 | |
| Coexpression | NABA_MATRISOME | COL6A2 RELN IL16 GDF6 SLIT3 ADAMTS16 SEMA6A MSTN MUC5AC GDF11 HCFC1 | 1.33e-05 | 1008 | 59 | 11 | MM17056 |
| Coexpression | NABA_MATRISOME | COL6A2 RELN IL16 GDF6 SLIT3 ADAMTS16 SEMA6A MSTN MUC5AC GDF11 HCFC1 | 1.56e-05 | 1026 | 59 | 11 | M5889 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.30e-09 | 191 | 59 | 7 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.37e-09 | 199 | 59 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.88e-08 | 128 | 59 | 6 | 2cf0384240a4a663869cf6b27d954236f6214a9a | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.96e-07 | 190 | 59 | 6 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-07 | 192 | 59 | 6 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-07 | 192 | 59 | 6 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.22e-07 | 194 | 59 | 6 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.22e-07 | 194 | 59 | 6 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.19e-06 | 140 | 59 | 5 | 7cc891d676555609add6fc7880735d948a2ad801 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-FB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.22e-06 | 159 | 59 | 5 | b4bc888e978b1b577721b891b0af6ba9a1607044 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Lymphatic_ECs|Endothelial_cells / Location, Cell class and cell subclass | 3.65e-06 | 176 | 59 | 5 | 42541dfe20eb29625d47c0bb79bf3c21a2460340 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.66e-06 | 185 | 59 | 5 | f9f48251bc33eb6bf2cff580d1a3207d21450aa0 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.17e-06 | 189 | 59 | 5 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.17e-06 | 189 | 59 | 5 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.17e-06 | 189 | 59 | 5 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | NS-critical-d_0-4|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.44e-06 | 191 | 59 | 5 | 769942a6a31c13c583dc38e8a762df2f5c06c2fb | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.58e-06 | 192 | 59 | 5 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.58e-06 | 192 | 59 | 5 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.58e-06 | 192 | 59 | 5 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.58e-06 | 192 | 59 | 5 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.58e-06 | 192 | 59 | 5 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.58e-06 | 192 | 59 | 5 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | -Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 6.01e-06 | 195 | 59 | 5 | e5b0afbea85575851cf9eb50a9ac42c67bbf3d7c | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.32e-06 | 197 | 59 | 5 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.32e-06 | 197 | 59 | 5 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.64e-06 | 199 | 59 | 5 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.64e-06 | 199 | 59 | 5 | fbec5c034576cb1adaf05f6f97cc5525d19e0c1b | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.64e-06 | 199 | 59 | 5 | 38ed3bc7daa993d9edcf3e7834597ebb06dd24f8 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.64e-06 | 199 | 59 | 5 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 6.64e-06 | 199 | 59 | 5 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 6.64e-06 | 199 | 59 | 5 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.64e-06 | 199 | 59 | 5 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 6.64e-06 | 199 | 59 | 5 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | (5)_Fibroblast-F|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.64e-06 | 199 | 59 | 5 | 1f66db4f502de4a5159cde90fcb3befb26b8d375 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.80e-06 | 200 | 59 | 5 | 93c1db92e0e456101f7895867fc8a1fe45298347 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.80e-06 | 200 | 59 | 5 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Mesothelial-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 6.80e-06 | 200 | 59 | 5 | 3be373e9a30e19334e4709e2819fb83cc777d104 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.80e-06 | 200 | 59 | 5 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.80e-06 | 200 | 59 | 5 | 46d0ae385e67030bfaf7062bb6b43da5db05b33a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.80e-06 | 200 | 59 | 5 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.80e-06 | 200 | 59 | 5 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Esm1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.02e-05 | 121 | 59 | 4 | 056d0f0f7a4d1b2d38b83647bbe4468b7c959ce6 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.60e-05 | 129 | 59 | 4 | f83187c0bb06528127b8d2d56674ab1946846951 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Eya1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.02e-05 | 134 | 59 | 4 | 657ad905b40ec3f82acdef824431b8276d291ef7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-05 | 135 | 59 | 4 | 88f86bab637f1ca1439c7de2d12be4329cf662b8 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Atp2b4-Inhibitory_Neuron.Gad1Gad2_Sst.Atp2b4_(Interneuron,_Olm)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.12e-05 | 46 | 59 | 3 | 1259dca3ada3ba697ce50268163bd3b63e3c77bc | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Atp2b4|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.12e-05 | 46 | 59 | 3 | 457e258b9b38e581b69ff92fc02d552c24d841cf | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Atp2b4-Inhibitory_Neuron.Gad1Gad2_Sst.Atp2b4_(Interneuron,_Olm)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.12e-05 | 46 | 59 | 3 | 5c1cd6647dd412162273fa01a73f65d62d422038 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Cdh13|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.20e-05 | 136 | 59 | 4 | 1f3000d5f105c87c80f8ae1dd2264bcd7f757a9c | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_2|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.38e-05 | 138 | 59 | 4 | 05de2cef97c0912fb23f138dd45348f565a14d74 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.48e-05 | 139 | 59 | 4 | 9e9f29f92dbe65b26cc78b3a1c00778c6a701f5b | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.58e-05 | 140 | 59 | 4 | b9aeb7dda7f377b580dd8a44912f300721437387 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.89e-05 | 143 | 59 | 4 | 24fd24846fbef049af669a57d42fcc18928d2b27 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.93e-05 | 152 | 59 | 4 | fed80b467ec9e30c7f98bed6cc4f8c583b715e9e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Sema3c|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.32e-05 | 155 | 59 | 4 | 5c7b68b59244525e3714806c205a57a2daebf423 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.59e-05 | 157 | 59 | 4 | 516903469756c5fabfdf56d7bd59b3bdd7b44e39 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 5.88e-05 | 159 | 59 | 4 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-05 | 159 | 59 | 4 | d2de9391b00b6c47f5fe28a1bad6da2097107ee0 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-05 | 159 | 59 | 4 | da6b7f8039adc19839d6c090a0b3d68fb6445a79 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-05 | 160 | 59 | 4 | 8590281165eab6514a9f6a022b900d4c222c1044 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.17e-05 | 161 | 59 | 4 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | Control-Mast_cells-Transitioning_MDM|Control / group, cell type (main and fine annotations) | 6.17e-05 | 161 | 59 | 4 | 5807ee48f871a3eb24ebf78fd107cf5f2a4ec846 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.17e-05 | 161 | 59 | 4 | dccb61d5e17a8f1c6d1fc146ee389f567659a0f0 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.17e-05 | 161 | 59 | 4 | b9a63fc9becc44d305fc7c221283bf59ec06b10f | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.17e-05 | 161 | 59 | 4 | 60f433eab9d5531bdf6aa86b0265f20b866b904c | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 6.47e-05 | 163 | 59 | 4 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.78e-05 | 165 | 59 | 4 | 8a82e20c9b1156bb4bbc16f7785abb04458d671b | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.11e-05 | 167 | 59 | 4 | 805129f887078340b260aa136b0ba19f2bd6ea03 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.11e-05 | 167 | 59 | 4 | 31cf8bf2eb523f6e7e319620648ff37fc09e2601 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.11e-05 | 167 | 59 | 4 | 3acb18428d1d33ad430c2fd031b1a91baee3c01d | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.27e-05 | 168 | 59 | 4 | 6db453cbbbaf4144a86fadcfa5805d33396713b5 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.44e-05 | 169 | 59 | 4 | bb43abad2c049b7f4d307737347290e01b3339a3 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.44e-05 | 169 | 59 | 4 | 5f18e3f40a5b1b167903f37516ec8181e889c7c5 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.44e-05 | 169 | 59 | 4 | 8bfa2d3bb541d02f55d7c95b8fd156c8403befca | |
| ToppCell | Endothelial-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 7.44e-05 | 169 | 59 | 4 | 8889c9e8af1ab0b093d57b69abd80b59b3461be9 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.61e-05 | 170 | 59 | 4 | 8ab67e2b6e30fdf9e9a2c02e31d4df34e751a3ed | |
| ToppCell | Endothelial-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 7.79e-05 | 171 | 59 | 4 | 07ff7059071da83da1d8f266a586573920d75b58 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-suprabasal_interpapillary|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-05 | 172 | 59 | 4 | 6ece9bb9f31685c918ca4cb7b82cf6ad1cad48af | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.15e-05 | 173 | 59 | 4 | 85083b9ce20351dd69aa2327ad087b848b4307ff | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.15e-05 | 173 | 59 | 4 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_CD24|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.33e-05 | 174 | 59 | 4 | 3e29d620b7b4ab1915ddac70ee5a50d09072292b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.52e-05 | 175 | 59 | 4 | 12f5fd83c7710fc0c77406f765d9cbd133433b8b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.10e-05 | 178 | 59 | 4 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.29e-05 | 179 | 59 | 4 | dc6cd46fa652b296ddbc41855f6377946d0a4cdc | |
| ToppCell | COVID-19-kidney-REN+Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 9.29e-05 | 179 | 59 | 4 | 342c1cc4444f51b8dcb30d3adc98285a25669c6e | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.50e-05 | 180 | 59 | 4 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 9.50e-05 | 180 | 59 | 4 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.50e-05 | 180 | 59 | 4 | d9dae9db8e17f6990032ee6cfa8393fae4768ca5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.50e-05 | 180 | 59 | 4 | 5bf5878be3230d38c8e65fb954f326d567e1b520 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.70e-05 | 181 | 59 | 4 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.70e-05 | 181 | 59 | 4 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.91e-05 | 182 | 59 | 4 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.91e-05 | 182 | 59 | 4 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.91e-05 | 182 | 59 | 4 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.91e-05 | 182 | 59 | 4 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 9.91e-05 | 182 | 59 | 4 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 184 | 59 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.03e-04 | 184 | 59 | 4 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 184 | 59 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 184 | 59 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| Disease | vertebral hypersegmentation and orofacial anomalies (implicated_via_orthology) | 3.93e-06 | 2 | 59 | 2 | DOID:0070418 (implicated_via_orthology) | |
| Disease | 1,5 anhydroglucitol measurement | 2.67e-05 | 29 | 59 | 3 | EFO_0008009 | |
| Disease | Osteitis Deformans | 1.40e-04 | 9 | 59 | 2 | C0029401 | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 2.56e-04 | 12 | 59 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | hypothyroidism (biomarker_via_orthology) | 5.59e-04 | 80 | 59 | 3 | DOID:1459 (biomarker_via_orthology) | |
| Disease | visceral adipose tissue measurement, body mass index | 7.14e-04 | 87 | 59 | 3 | EFO_0004340, EFO_0004765 | |
| Disease | chronic obstructive pulmonary disease (is_marker_for) | 9.80e-04 | 97 | 59 | 3 | DOID:3083 (is_marker_for) | |
| Disease | Major Depressive Disorder | 1.43e-03 | 243 | 59 | 4 | C1269683 | |
| Disease | susceptibility to rheumatic fever measurement | 1.44e-03 | 28 | 59 | 2 | EFO_0008416 | |
| Disease | muscular atrophy (biomarker_via_orthology) | 1.54e-03 | 29 | 59 | 2 | DOID:767 (biomarker_via_orthology) | |
| Disease | pulse pressure measurement | 1.69e-03 | 1392 | 59 | 9 | EFO_0005763 | |
| Disease | Unipolar Depression | 1.81e-03 | 259 | 59 | 4 | C0041696 | |
| Disease | Mental Retardation, X-Linked 1 | 1.88e-03 | 32 | 59 | 2 | C2931498 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CCAERPKPGPTGVKT | 6 | Q6PL45 | |
| CKLPPQSSGVDTSPC | 346 | O75815 | |
| VTGLVPCKVSACPPS | 916 | Q8TE57 | |
| SCQLKSPCPLGASPG | 1226 | Q8TDY8 | |
| CSPTTCSPLSPGKGA | 261 | Q17RG1 | |
| SSPPTCSVKSPQGCV | 1741 | Q8WYB5 | |
| CLPGFPGAPCAIKIS | 1886 | P51610 | |
| PTEGACAPGKPTLVC | 726 | Q9Y5I1 | |
| DCGPGKPTLVCSSAV | 731 | Q9Y5H8 | |
| LCQGPSLASKPVPCS | 241 | Q14667 | |
| GPKLGTCPSRPSCSM | 211 | Q7Z418 | |
| PPTSGGFLKLSKPCC | 26 | P78559 | |
| VTCAGKGTPLTPPAC | 876 | Q8TD19 | |
| KGTPLTPPACACSSL | 881 | Q8TD19 | |
| GVCGPSPPCITTVSV | 86 | P78386 | |
| LLSPSGPVCTCPNGK | 4161 | Q07954 | |
| HGPCPVTTFGPKACV | 66 | O95544 | |
| PPGCGKTTVVAAACS | 471 | Q13608 | |
| CAQTPCIPKEGASPT | 1011 | Q14005 | |
| TATTGPPPKLCLVCS | 411 | P04150 | |
| CETPKGCPVTSTPVT | 4051 | P98088 | |
| PGAGTAPKPVSVACT | 1096 | Q8WXE0 | |
| AGVISVPSKCPAGTC | 846 | A8MWY0 | |
| PQCLPADPKCSGSVS | 2791 | P78509 | |
| CSAAPTEGACGPVKP | 721 | Q9Y5I2 | |
| PQIPATCEPGKVCGA | 51 | Q9H8W2 | |
| AGPACVTVILPSCVP | 611 | Q9P2G3 | |
| CATPVESPLCPSLGK | 1231 | Q14CM0 | |
| TTAAGPPGQCKAPCI | 761 | Q53EP0 | |
| ATPGGLPAPCASKVE | 11 | Q9UBL6 | |
| CFPGLCEGKSTLVPT | 131 | Q9BY84 | |
| CYKVSCLEIPGPSGP | 246 | P12110 | |
| GSAGPCCTPTKMSPI | 366 | O95390 | |
| PAGSPKGCFACVSKP | 66 | A6NMD0 | |
| TPPICSFTKGECHVP | 136 | Q9BXR6 | |
| GSSCPTPAKFNTCPL | 216 | Q9ULV5 | |
| SLSKTCSPACPIPEG | 66 | Q16553 | |
| CKPVGSVPICSGASS | 281 | P60372 | |
| PCLSAMGCPPGATFK | 1476 | Q9Y4K1 | |
| PSPPAGTLTCELKSC | 686 | O95180 | |
| ECVTVKPGTPSPACP | 156 | Q8N1N2 | |
| CPSGDKCPLVGSSVP | 546 | Q8IU81 | |
| DPGSTPPSCCVPTKL | 411 | Q6KF10 | |
| PPACRKGLPCSGKSS | 316 | Q9Y3M8 | |
| TVVPGKCPSPGCQEA | 521 | Q9UIG8 | |
| NPRGSAGPCCTPTKM | 331 | O14793 | |
| PSSCCSDPSKPGGNV | 286 | Q13501 | |
| PGCTKVPEPGCTKVP | 56 | Q9UBC9 | |
| VPEPGCTKVPEPGCT | 61 | Q9UBC9 | |
| SALPMCGPICPSAGS | 471 | Q86UX6 | |
| LPPQSLGVSPGCKSC | 1321 | O75094 | |
| ESGPRPTATPCGCVK | 6 | Q9BU70 | |
| PTATPCGCVKPALET | 11 | Q9BU70 | |
| PSAPVGKEGSCVPLS | 336 | P43119 | |
| ENLPPSTGPCCTKVT | 3151 | Q15413 | |
| TPNCVPVEGPGCTKE | 121 | Q96PX9 | |
| VPKPRPGCCAGSSSL | 361 | Q9H2E6 | |
| PKSGEVTPSCPLLCE | 831 | P29144 | |
| SPLPASGGPLTCKVC | 1191 | Q8N1G0 | |
| KSPKLCNPTGPTVSC | 731 | Q9UI33 | |
| CGVTPTAPACPGKVH | 246 | Q00G26 | |
| KGTVPVPEGCSPCSV | 541 | Q9BRZ2 | |
| PPPCQKAPSGLVTSC | 396 | Q8N5Q1 |